Boston Partners grew its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 31.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 164,021 shares of the company's stock after purchasing an additional 39,250 shares during the quarter. Boston Partners owned about 0.07% of HCA Healthcare worth $56,677,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently added to or reduced their stakes in HCA. Cheviot Value Management LLC acquired a new position in HCA Healthcare in the first quarter valued at about $26,000. Atwood & Palmer Inc. bought a new position in shares of HCA Healthcare during the first quarter worth about $28,000. Bartlett & CO. Wealth Management LLC boosted its position in HCA Healthcare by 888.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after purchasing an additional 80 shares during the last quarter. ORG Partners LLC lifted its holdings in HCA Healthcare by 344.0% during the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after purchasing an additional 86 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. raised its holdings in HCA Healthcare by 75.8% in the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock valued at $40,000 after acquiring an additional 50 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.
HCA Healthcare Stock Performance
Shares of HCA traded up $7.4980 on Wednesday, reaching $410.1880. 1,639,519 shares of the company's stock traded hands, compared to its average volume of 1,471,573. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. The stock has a market cap of $95.98 billion, a PE ratio of 17.24, a PEG ratio of 1.27 and a beta of 1.39. The stock's 50 day simple moving average is $372.57 and its two-hundred day simple moving average is $352.94. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14.
HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same period last year, the business posted $5.50 earnings per share. HCA Healthcare's revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.
HCA Healthcare Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be paid a dividend of $0.72 per share. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare's payout ratio is 12.11%.
Wall Street Analysts Forecast Growth
HCA has been the subject of a number of recent research reports. Wells Fargo & Company lowered their target price on HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating for the company in a report on Thursday, August 14th. Stephens upgraded HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. JPMorgan Chase & Co. upped their target price on HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. Barclays dropped their price target on HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating on the stock in a research note on Monday, July 28th. Finally, Truist Financial upped their price target on HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a research note on Wednesday, July 16th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $398.58.
Read Our Latest Report on HCA
HCA Healthcare Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Stories

Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.